Stroke Gait Rehabilitation Using Functional Electrical Stimulation
17. februar 2021 oppdatert av: Trisha Kesar, PT, PhD, Emory University
Cortical and Spinal Correlates of Post-stroke Gait Rehabilitation
The study is a prospective interventional study to assess the changes in corticospinal excitability and spinal reflex excitability of in response to rehabilitative strategies and protocols that are commonly used during physical therapy treatment of gait disorders among post-stroke subjects.
As part of this protocol, 55 individuals with chronic stroke will be assigned to either Cohort 1 or Cohort 2, and will participate in 1-18 gait training sessions.
If interested, study participants can also complete both study cohorts sequentially (with at least 3-weeks duration between switching from one cohort to the second).
The study examines the effects among two cohorts of post stroke patients.
Cohort 1 will participate in 18 sessions of fast treadmill walking plus Functional Electrical Stimulation (FastFES) and Cohort 2 will participate in 1-3 sessions of FastFES and fast walking without FES.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Stroke is the number one cause of disability. Difficulty with walking affects most stroke survivors. Walking deficits (e.g. reduced ankle flexion during swing phase, decreased forward propulsion during terminal stance) can cause risks of falls, slow walking speed, increased effort of walking, and difficulties with activities of daily living. Restoration of walking ability can improve quality of life, and is perceived as a major goal of rehabilitation by stroke survivors. Examples of interventions that are used to rehabilitate walking post-stroke are functional electrical stimulation, fast treadmill walking, and bio- feedback. While recent research has focused on comparing the effectiveness of different gait rehabilitation interventions, the neural and biomechanical mechanisms underlying different gait rehabilitation strategies are unknown. FastFES is a novel gait training intervention that combines the beneficial effects of two independent interventions: Fast treadmill walking and FES. The FastFES intervention incorporates principles of physiology, biomechanics, motor control and learning, and predictions of forward-dynamic gait simulations to improve post-stroke gait.
The overall purpose of this protocol is to assess the biomechanical and neurophysiologic effects of rehabilitative strategies and protocols that are commonly used during physical therapy treatment of gait disorders post-stroke among two cohorts of people. Aim 1 of the study will assess the changes in gait biomechanics, corticospinal excitability, and walking function during 18 sessions of gait retraining, with participants in Cohort 1. Aim 2 of the study assesses the effect of parameters such as walking speed (slow, fast, variable, split-belt walking), functional electrical stimulation parameters (short-term changes induced by fast versus FastFES, stimulation intensity, number of muscles stimulated), and bio-feedback on within-session changes in gait biomechanics, walking function, and corticospinal excitability, among participants in Cohort 2.
Within Cohort 1, participants will receive identical treatment throughout the 18 training sessions (i.e. FastFES training). Within Cohort 2, participants will participate in 3 training sessions of both FastFES and fast walking training, with a 3-week break between the two types of training.
Studietype
Intervensjonell
Registrering (Faktiske)
24
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30322
- Emory University
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
30 år til 80 år (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Chronic stroke (>6 months post stroke)
- First (single) lesion
- Able to walk with or without the use of a cane or walker
- Sufficient cardiovascular health and ankle stability to walk for 6 minutes at a self-selected speed without an orthoses
- Resting heart rate 40-100 beats per minute
- Resting blood pressure between 90/60-70/90
Exclusion Criteria:
- Evidence of moderate/ severe chronic white matter disease or cerebellar stroke on MRI
- Cerebellar signs (ataxic ("drunken") gait or decreased coordination during rapid alternating hand or foot movements
- Insulin dependent diabetes
- History of lower extremity joint replacement
- Score of >1 on question 1b and >0 on question 1c on NIH Stroke Scale
- Inability to communicate with investigators
- Neglect/hemianopia, or unexplained dizziness in last 6 months
- Neurologic conditions other than stroke
- Orthopedic problems in the lower limbs or spine (or other medical conditions) that limit walking
- Contraindications to transcranial magnetic stimulation (TMS) are: history of seizures, metal implants in the head or face, history of recurring or severe headaches/migraine, headache within the past 24 hours, presence of skull abnormalities or fractures, hemorrhagic stroke, history of dizziness, syncope, nausea, or loss of consciousness in the past 12 months
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Cohort 1 - FastFES Training
Participants with chronic stroke in Cohort 1 will receive 18 training sessions of FastFES (fast treadmill walking with electrical stimulation).
|
Functional electrical stimulation (FES) is a technique that causes a muscle to contract through the use of an electrical current.
The therapist applies an electrical current to either the skin over the nerve, or over the bulk of the muscle, and this will cause a muscle contraction.
The FES is delivered to 2 muscle groups (dorsiflexor and plantarflexor) timed appropriately with the gait cycle.
FastFES gait training sessions may comprise up to six 6-minute bouts of walking with rest breaks between bouts (total 30-minutes of walking).
The last training bout (bout 6) may comprise 6-minutes of over ground walking, during which subjects will be asked to walk as fast as they can.
For safety, a physical therapist will walk with and guard the subject during over ground walking.
Andre navn:
|
|
Eksperimentell: Cohort 2 - FastFES and Fast Walking
Participants with chronic stroke in Cohort 2 who complete 3 sessions of FastFES and 3 sessions of fast walking.
|
Functional electrical stimulation (FES) is a technique that causes a muscle to contract through the use of an electrical current.
The therapist applies an electrical current to either the skin over the nerve, or over the bulk of the muscle, and this will cause a muscle contraction.
The FES is delivered to 2 muscle groups (dorsiflexor and plantarflexor) timed appropriately with the gait cycle.
FastFES gait training sessions may comprise up to six 6-minute bouts of walking with rest breaks between bouts (total 30-minutes of walking).
The last training bout (bout 6) may comprise 6-minutes of over ground walking, during which subjects will be asked to walk as fast as they can.
For safety, a physical therapist will walk with and guard the subject during over ground walking.
Andre navn:
Fast walking training sessions will be similar to FastFES in duration, dosage, structure but no FES will be provided.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Motor Evoked Potentials (MEP) Amplitude Measure in milliVolt (mV) of FastFES Versus Fast Walking After 3 Training Sessions in Cohort 2
Tidsramme: Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change from baseline in MEP amplitude (transverse abdominal (TA) muscle) is used as a measure of corticospinal excitability that is assessed using a non-invasive technique called transcranial magnetic stimulation (TMS).
Electrical activity from muscles in response to the TMS will be collected using surface electromyography (EMG) sensors attached to muscles that play critical roles during FastFES versus Fast walking.
TMS will be delivered using two Magstim 200 stimulators connected via a BiStim module.
An average of 10 TMS-evoked MEP responses will be used to comparing mean peak-to-peak MEP amplitudes in response to suprathreshold TMS delivered to the hotspot.
|
Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
|
Change in H-Reflex /M-Wave (Hmax/Mmax) Ratio Among FastFES Versus Fast Walking After 3 Training Sessions in Cohort 2
Tidsramme: Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change from baseline in (Hmax/Mmax) ratio is used as a measure of spinal reflex excitability, that is assessed using peripheral electrical stimulation delivered to the nerves innervating the ankle muscles.
An electrical stimulation electrode is placed just above the knee, and used as the anode for tibial nerve stimulation.
Electrical stimulation is delivered via surface electrodes in a static position to the popliteal fossa.
The subject's EMG activity will be recorded while the cathode is moved at the back of the knee to determine the location that provides the best EMG response (H-reflex).
EMG activity will be recorded while 50-60 electrical stimuli (short 1 ms square pulses, ranging in intensity in milliAmpere(mA) 1-80), 7-10 seconds apart, are delivered to the muscle.
Also 5-20 electrical stimulus pulses at intensities are delivered that elicit a percentage of the maximum reflex response.
|
Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
|
Change in Motor Evoked Potentials (MEP) Amplitude Measure in milliVolt (mV) of FastFES After 18 Training Sessions in Cohort 1
Tidsramme: Baseline and up to 6 weeks
|
Change from baseline in MEP amplitude (TA muscle in a resting state) is used as a measure of corticospinal excitability that is assessed using a non-invasive technique called transcranial magnetic stimulation (TMS).
Electrical activity from muscles in response to the TMS will be collected using surface electromyography (EMG) sensors attached to muscles that play critical roles during FastFES versus Fast walking.
TMS will be delivered using two Magstim 200 stimulators connected via a BiStim module.
An average of 10 TMS-evoked MEP responses will be used to comparing mean peak-to-peak MEP amplitudes in response to suprathreshold TMS delivered to the hotspot.
|
Baseline and up to 6 weeks
|
|
Change in H-Reflex /M-Wave (Hmax/Mmax) Ratio Among FastFES Versus Fast Walking After 18 Training Sessions in Cohort 1
Tidsramme: Baseline and up to 6 weeks
|
Change from baseline in (Hmax/Mmax) ratio is used as a measure of spinal reflex excitability, that is assessed using peripheral electrical stimulation delivered to the nerves innervating the ankle muscles.
An electrical stimulation electrode is placed just above the knee, and used as the anode for tibial nerve stimulation.
Electrical stimulation is delivered via surface electrodes in a static position to the popliteal fossa.
The subject's EMG activity will be recorded while the cathode is moved at the back of the knee to determine the location that provides the best EMG response (H-reflex).
EMG activity will be recorded while 50-60 electrical stimuli (short 1 ms square pulses, ranging in intensity in milliAmpere(mA) 1-80), 7-10 seconds apart, are delivered to the muscle.
Also 5-20 electrical stimulus pulses at intensities are delivered that elicit a percentage of the maximum reflex response.
|
Baseline and up to 6 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Peak Anterior Ground Reaction Force (AGRF) of FastFES Versus Fast Walking After 3 Training Sessions in Cohort 2
Tidsramme: Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change from baseline in peak AGRF during treadmill walking will be collected using a treadmill instrumented with two force platforms under each belt.
Motion analysis data will be collected during 15- to 40-second long dynamic walking trials as subjects walk on a treadmill.
|
Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
|
Change in Peak Anterior Ground Reaction Force (AGRF) of FastFES Versus Fast Walking After 18 Training Sessions in Cohort 1
Tidsramme: Baseline and up to 6 weeks
|
Change from baseline in peak AGRF during treadmill walking will be collected using a treadmill instrumented with two force platforms under each belt.
Motion analysis data will be collected during 15- to 40-second long dynamic walking trials as subjects walk on a treadmill.
|
Baseline and up to 6 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Trisha Kesar, PT, PhD, Emory University
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. august 2013
Primær fullføring (Faktiske)
1. mai 2019
Studiet fullført (Faktiske)
1. mai 2019
Datoer for studieregistrering
Først innsendt
15. august 2012
Først innsendt som oppfylte QC-kriteriene
16. august 2012
Først lagt ut (Anslag)
20. august 2012
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
10. mars 2021
Siste oppdatering sendt inn som oppfylte QC-kriteriene
17. februar 2021
Sist bekreftet
1. februar 2021
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- IRB00058363
- 5K01HD079584-02 (U.S. NIH-stipend/kontrakt)
- 13SDG13320000 (Annen identifikator: American Heart Association)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Ja
produkt produsert i og eksportert fra USA
Ja
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .